UK small-cap RNS · 4 Mar 2026

Every announcement of UK small & mid caps under £2bn. The ones that started or moved a situation are marked – a click opens it.

Key = all announcements except routine filings (voting rights, buybacks, holdings, director forms), plus the ones that are part of a situation. Not investment advice.

Sort: Newest · Largest companies

16:45

Faron Pharmaceuticals Oy FARN £66m
Faron Pharmaceuticals Ltd’s Annual Report 2025 published Results
The Annual Report 2025 published did not contain the auditor’s report.

+4.9% on the day
12:34

Neo Energy Metals NEO £15m
Annual Report Results
Neo Energy Metals plc / LSE: NEO, A2X: NEO / Market: Main Market of the London Stock Exchange

+0.0% on the day
10:18

SIG SHI £109m
Annual Report Results
The Company announces that it has today published its 2025 Annual Report & Accounts (the "2025 Annual Report").

−1.0% on the day
07:15

Faron Pharmaceuticals Oy FARN £66m
Faron Pharmaceuticals Ltd’s Annual Report 2025 published Results
The Annual Report contains the Report of the Board of Directors, the Financial Statements for 2025 and the Remuneration Report.

+13.7% on the day
07:00

Cairn Homes (CDI) CRN £1,402m
2025 Preliminary Results Results
+3.9% on the day
07:00

Metro Bank Holdings PLC MTRO £1,091m
Results for the year ended 31 December 2025 Results
Metro Bank Holdings PLC: Results for the year ended 31 December 2025

in linefirst in 7 months −1.9% on the day
07:00

Allergy Therapeutics AGY £285m
Positive Biomarker Results from PROTECT Trial Results
Interim biomarker data show a consistent immune response to VLP Peanut and give early proof of concept after the safety endpoint, supporting the move to Phase IIb. Efficacy by food challenge is still untested and the cohorts are very small.

outlook positive −6.0% on the day

Moved: VLP Peanut PROTECT trial: Primary safety endpoint met; follow-up ongoing → Primary safety met; biomarker data positive
07:00

Vistry Group VTY £806m
Final Results Results
FY25 adjusted profit before tax of £268.8m met guidance and rose 2%, but revenue and completions fell, no new distribution is proposed, and 2026 margin will be lower because of sales incentives.

Upgrade / downgrade cycle £268.8m · 33% of mcapin lineoutlook mixedfirst since Oct 2023 −25.6% on the day

Moved: Complete £130m share buyback by the May 2025 AGM: pending → delayed – £29m of the £130m buyback programme is still to be completed, so it was not finished by the May 2025 AGM. · Return £1bn to shareholders over three years via ordinary and special distributi: pending → changed – No further capital distribution proposed on the 2025 results to prioritise debt reduction; future distributions to be reviewed at the half year. · Reduce excess working capital by about £200m in FY25: pending → delayed – Weak Open Market conditions slowed inventory reduction in 2025, so working capital release is pushed into 2026.
07:00

Galliford Try GFRD £675m
Half-year Results Results
H1 adjusted PBT rose 20.5% to £24.7m on a stronger margin, and full-year revenue and adjusted PBT are now guided above the top of the market range, after January's 'slightly above' guidance.

ahead of expectationsoutlook positive, raised +7.3% on the day
07:00

MTI Wireless Edge Ltd. MWE £55m
Final Results Results
A year of record revenue alongside continued growth in earnings per share and dividend

+2.7% on the day
07:00

SIG SHI £109m
Final Results Results
Full year results for the year ended 31 December 2025

Upgrade / downgrade cycle in lineoutlook mixedfirst since Oct 2023 −1.0% on the day

Moved: Reach 5% operating margin over the medium term: changed → on_track – Board reiterates confidence in delivering the 3-5% operating margin range in the medium term, against 1.2% in FY25. · Return to paying a dividend when prudent: pending → delayed – No dividend for 2025; the Board only reiterates a commitment to return to paying one when prudent. · Vision 2030 and portfolio review: Early-phase portfolio review; Mayplas closed → Portfolio review ongoing; procurement savings from 2027
07:00

Netcall NET £218m
Half-year Results Results
First half after the Jadu deal shows 15% revenue growth, 11% organic, and adjusted EBITDA and EPS up. Management says revenue is in line with its expectations, so the beat is not a surprise, but statutory profit before tax fell 31%.

in lineoutlook positivefirst in 7 months −1.0% on the day

Moved: Jadu acquisition integration and earn-out: Completed; integration and earn-out period begin → Integration progressing well; initial contribution in H1
07:00

Mila Resources MILA £8.4m
Half-year Results Results
Mila Resources Plc / Index: LSE / Epic: MILA / Sector: Natural Resources

−2.4% on the day